Trade alert for break above Point of Control (redline) Earnings highlights Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. Q4 GAAP EPS of -$0.08 in-line. Revenue of 1.22M (-1.6% Y/Y) beats by 0.29M.